Harbour Investments’s Fulgent Genetics FLGT Stock Holding History

Harbour Investments’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-136	Closed	-$13K	–	3817
2021 Q2	$13K	Buy	136 +30	+28%	+$2.4K	﹤0.01%	2581
2021 Q1	$10K	Buy	+106	New	+$10.9K	﹤0.01%	2602

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Harbour Investments's FLGT Position: Q3 2021 in Review

Harbour Investments sold out of Fulgent Genetics (FLGT) in Q3 2021, closing a stake of 136 shares — an estimated $13K sold.

Harbour Investments first reported a position in FLGT in Q1 2021 and held it in 2 quarters. The position peaked at $13K in Q2 2021. 268 funds tracked by Wall St. Rank hold FLGT as of Q3 2021.

Harbour Investments reported no remaining Fulgent Genetics position as of Q3 2021 after selling out during the quarter.
Harbour Investments sold 136 Fulgent Genetics shares in Q3 2021, an estimated $13K.
Harbour Investments first reported a position in Fulgent Genetics in Q1 2021 and held it in 2 quarters.
Harbour Investments's Fulgent Genetics position peaked at $13K in Q2 2021.
268 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2021.

Based on Harbour Investments's 13F filing for Q3 2021, filed 15 Nov 2021.